Eric S. Bennett

Eric S. Bennett

Auto-generated profile, based on publicly available information

Eric S. Bennett

College of Science and Mathematics, Wright State University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 August 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
AEAndrew R. Ednie
Andrew R. Ednie
WDWei Deng
Wei Deng
Kay-Pong YipKay-Pong Yip
Kay-Pong Yip
EBEric S. Bennett
Eric S. Bennett
Protein glycosylation is an essential posttranslational modification that affects a myriad of physiologic processes. Humans with genetic defects in glycosylation, which result in truncated glycans, often present with significant cardiac deficits. Acquired heart diseases and their associated risk factors were also linked to aberrant glycosylation, highlighting its importance in human cardiac disease. In both cases, the link between causation and corollary remains enigmatic. The glycosyltransferase gene, mannosyl (α‐1,3‐)‐glycoprotein β‐1,2‐ N ‐acetylglucosaminyltransferase (Mgat1), whose product, N ‐acetylglucosaminyltransferase 1 (GlcNAcT1) is necessary for the formation of hybrid and complex N ‐glycan structures in the medial Golgi, was shown to be at reduced levels in human end‐stage cardiomyopathy, thus making Mgat1 an attractive target for investigating the role of hybrid/complex N ‐glycosylation in cardiac pathogenesis. Here, we created a cardiomyocyte‐specific Mgatl knockout (KO) mouse to establish a model useful in exploring the relationship between hybrid/complex N ‐glycosylation and cardiac function and disease. Biochemical and glycomic analyses showed that Mgat1KO cardiomyocytes produce predominately truncated N ‐glycan structures. All Mgat1KO mice died significantly younger than control mice and demonstrated chamber dilation and systolic dysfunction resembling human dilated cardiomyopathy (DCM). Data also indicate that a cardiomyocyte L‐type voltage‐gated Ca 2+ channel (Ca v ) subunit (α281) is a GlcNAcT1 target, and Mgat1KO Ca v activity is shifted to more‐depolarized membrane potentials. Consistently, Mgat1KO cardiomyocyte Ca 2+ handling is altered and contraction is dyssynchronous compared with controls. The data demonstrate that reduced hybrid/complex N ‐glycosylation contributes to aberrant cardiac function at whole‐heart and myocyte levels drawing a direct link between altered glycosylation and heart disease. Thus, the Mgat1KO provides a model for investigating the relationship between systemic reductions in glycosylation and cardiac disease, showing that clinically relevant changes in cardiomyocyte hybrid/complex N ‐glycosylation are sufficient to cause DCM and early death.—Ednie, A. R., Deng, W., Yip, K.‐P., Bennett, E. S. Reduced myocyte complex N‐glycosylation causes dilated cardiomyopathy. FASEB J. 33, 1248–1261 (2019). www.fasebj.org

1 July 2025 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
MAMalak Abbas
Malak Abbas
PMPamela Martin
Pamela Martin
Merry L LindseyMerry L Lindsey
Merry L Lindsey
EBEric S. Bennett
Eric S. Bennett
TBThomas L. Brown
Thomas L. Brown
AGAmadou Gaye
Amadou Gaye
African American women experience a disproportionate burden of hypertension and chronic kidney disease, yet their molecular underpinnings remain understudied. This study uniquely integrates transcriptomic data from 344 African American women to uncover 95 female-specific genes jointly associated with hypertension and reduced kidney function. These genes implicate immune activation, cytoskeletal remodeling, and metabolic dysregulation as key contributors to renal decline. By identifying sex-specific molecular pathways, this work advances precision medicine approaches to address kidney health disparities.

15 October 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
AYAnthony M. Young
Anthony M. Young
JMJohn A. Miller
John A. Miller
AEAndrew R. Ednie
Andrew R. Ednie
EBEric S. Bennett
Eric S. Bennett
Background: Heart failure (HF) presents a massive burden to health care with a complex pathophysiology that results in HF with reduced left ventricle ejection fraction (EF) or HF with preserved EF. It has been shown that relatively modest changes in protein glycosylation, an essential posttranslational modification, are associated with clinical presentations of HF. We and others previously showed that such aberrant protein glycosylation in animal models can lead to HF. Methods and Results: We develop and characterize a novel, tamoxifen‐inducible, cardiomyocyte Mgat1 knockout mouse strain, achieved through deletion of Mgat1 , alpha‐1,3‐mannosyl‐glycoproten 2‐beta‐N‐acetlyglucosaminyltransferase, which encodes N‐acetylglucosaminyltransferase I. We investigate the role of hybrid/complex N‐glycosylation in adult HFrEF pathogenesis at the ion channel, cardiomyocyte, tissue, and gross cardiac level. The data demonstrate successful reduction of N‐acetylglucosaminyltransferase I activity and confirm that hybrid/complex N‐glycans modulate gating of cardiomyocyte voltage‐gated calcium channels. A longitudinal study shows that the tamoxifen‐inducible, cardiomyocyte Mgat1 knockout mice present with significantly reduced systolic function by 28 days post induction that progresses into HFrEF by 8 weeks post induction, without significant ventricular dilation or hypertrophy. Further, there was minimal, if any, physiologic or pathophysiologic cardiomyocyte electromechanical remodeling or fibrosis observed before (10–21 days post induction) or after (90–130 days post induction) HFrEF development. Conclusions: The tamoxifen‐inducible, cardiomyocyte Mgat1 knockout mouse strain created and characterized here provides a model to describe novel mechanisms and causes responsible for HFrEF onset in the adult, likely occurring primarily through tissue‐level reductions in electromechanical activity in the absence of (or at least before) cardiomyocyte remodeling and fibrosis.

6 February 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PBParmvir K. Bahia
Parmvir K. Bahia
EBEric S. Bennett
Eric S. Bennett
TTThomas E. Taylor-Clark
Thomas E. Taylor-Clark
It has long been recognized that divalent cations modulate cell excitability. Sensory nerve excitability is of critical importance to peripheral diseases associated with pain, sensory dysfunction and evoked reflexes. Thus we have studied the role these cations play on dissociated sensory nerve activity. Withdrawal of both Mg2+ and Ca2+ from external solutions activates over 90% of dissociated mouse sensory neurons. Imaging studies demonstrate a Na+ influx that then causes depolarization-mediated activation of voltage-gated Ca2+ channels (CaV), which allows Ca2+ influx upon divalent re-introduction. Inhibition of CaV (ω-conotoxin, nifedipine) or NaV (tetrodotoxin, lidocaine) fails to reduce the Na+ influx. The Ca2+ influx is inhibited by CaV inhibitors but not by TRPM7 inhibition (spermine) or store-operated channel inhibition (SKF96365). Withdrawal of either Mg2+ or Ca2+ alone fails to evoke cation influxes in vagal sensory neurons. In electrophysiological studies of dissociated mouse vagal sensory neurons, withdrawal of both Mg2+ and Ca2+ from external solutions evokes a large slowly-inactivating voltage-gated current (IDF) that cannot be accounted for by an increased negative surface potential. Withdrawal of Ca2+ alone fails to evoke IDF. Evidence suggests IDF is a non-selective cation current. The IDF is not reduced by inhibition of NaV (lidocaine, riluzole), CaV (cilnidipine, nifedipine), KV (tetraethylammonium, 4-aminopyridine) or TRPM7 channels (spermine). In summary, sensory neurons express a novel voltage-gated cation channel that is inhibited by external Ca2+ (IC50∼0.5 µM) or Mg2+ (IC50∼3 µM). Activation of this putative channel evokes substantial cation fluxes in sensory neurons.

16 December 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
JKJohn Karanja Kamau
John Karanja Kamau
AYAnthony Milard Young
Anthony Milard Young
CWClintoria Richards Williams
Clintoria Richards Williams
EBEric S. Bennett
Eric S. Bennett
AEAndrew R. Ednie
Andrew R. Ednie
HRHongmei Ren
Hongmei Ren
Background: Lipin1 has dual functions acting as phosphatidic acid phosphatase required for lipid synthesis and as a transcriptional coactivator. Our previous research demonstrated that lipin1 is critical for maintaining sarcolemmal integrity in skeletal muscle. Given the importance of sarcolemmal stability for cardiac muscle viability and function, we investigated the role of lipin1 in the heart using a novel cardiac‐specific lipin1 deficient ( Myh6‐lipin1 −/− ) mouse model. Methods: We characterized male Myh6‐lipin1 −/− mice at 3 to 4 months of age to assess cardiac structure and function. Results: Myh6‐lipin1 −/− mice exhibited marked cardiac inflammation, fibrosis, increased expression of cell death markers, and elevated sarcolemmal damage. Lipin1 deficiency led to disrupted sarcolemmal integrity, evidenced by decreased expression and mislocalization of key membrane structural proteins. Upon isoproterenol‐induced cardiac stress, lipin1‐deficient mice demonstrated significantly greater reductions in ejection fraction and fractional shortening compared with control mice. Conclusions: These findings reveal a critical role for lipin1 in maintaining cardiac sarcolemmal integrity and emphasize its importance in supporting normal cardiac morphology and function, particularly under stress conditions.